Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
2010204N 08Rik | |
NM_001081137 |
RIKEN cDNA 2010204N08 gene (2010204N08Rik), mRNA [NM_001081137] |
KLA | .99 |
.98 |
1.00 |
.96 |
.98 |
.98 |
.99 |
| ATP | .96 |
.98 |
1.06 |
1.14 |
.98 |
.97 |
.99 |
| KLA/ATP | .98 |
1.05 |
1.06 |
1.04 |
.99 |
.98 |
1.94 |
|
2310005E 10Rik | |
BC026843 |
RIKEN cDNA 2310005E10 gene, mRNA (cDNA clone IMAGE:4487182), complete cds. [BC026843] |
KLA | .70 |
.65 |
.65 |
.65 |
.83 |
.90 |
.89 |
| ATP | 1.00 |
.95 |
.75 |
.31 |
.29 |
.58 |
.80 |
| KLA/ATP | .69 |
.54 |
.49 |
.28 |
.36 |
.56 |
.53 |
|
2310005E 10Rik | |
NM_172398 |
RIKEN cDNA 2310005E10 gene (2310005E10Rik), mRNA [NM_172398] |
KLA | .78 |
.71 |
.71 |
.71 |
.69 |
.90 |
.82 |
| ATP | 1.01 |
.95 |
1.18 |
.89 |
.68 |
.44 |
.62 |
| KLA/ATP | .71 |
.70 |
.88 |
.67 |
.60 |
.59 |
.63 |
|
AK209324
| |
AK209324 |
cDNA, clone:Y2G0114L23, strand:plus, reference:ENSEMBL:Mouse-Transcript-ENST:ENSMUST00000060207, based on BLAT search. [AK209324] |
KLA | .48 |
.51 |
.55 |
.57 |
.80 |
.90 |
1.17 |
| ATP | 1.01 |
.96 |
.73 |
.60 |
.76 |
.78 |
1.24 |
| KLA/ATP | .54 |
.46 |
.42 |
.54 |
.76 |
.76 |
.73 |
|
Akr1b3 | |
AK054167 |
2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230024H01 product:unclassifiable, full insert sequence [AK054167] |
KLA | 1.06 |
.92 |
.98 |
1.01 |
1.02 |
1.04 |
.96 |
| ATP | 1.08 |
1.02 |
.99 |
.97 |
1.09 |
1.02 |
.99 |
| KLA/ATP | .99 |
1.01 |
.97 |
.99 |
1.02 |
.99 |
1.08 |
|
Akr1b3 | |
NM_009658 |
aldo-keto reductase family 1, member B3 (aldose reductase) (Akr1b3), mRNA [NM_009658] |
KLA | .97 |
.99 |
.96 |
.91 |
.92 |
.93 |
.77 |
| ATP | 1.08 |
1.13 |
1.09 |
1.15 |
1.00 |
1.03 |
1.18 |
| KLA/ATP | 1.06 |
.98 |
.95 |
1.15 |
.89 |
.88 |
.82 |
|
Akr1b7 | |
NM_009731 |
aldo-keto reductase family 1, member B7 (Akr1b7), mRNA [NM_009731] |
KLA | .92 |
.93 |
.93 |
.93 |
.97 |
.96 |
.84 |
| ATP | .97 |
1.01 |
.93 |
.88 |
.85 |
.95 |
.88 |
| KLA/ATP | .86 |
.92 |
.92 |
.82 |
.85 |
.94 |
1.02 |
|
Akr1b8 | |
NM_008012 |
aldo-keto reductase family 1, member B8 (Akr1b8), mRNA [NM_008012] |
KLA | .64 |
.56 |
.49 |
.46 |
.31 |
.25 |
.25 |
| ATP | .95 |
.97 |
1.17 |
.90 |
.85 |
2.25 |
2.02 |
| KLA/ATP | .55 |
.53 |
.63 |
.47 |
.50 |
1.00 |
2.18 |
|
B4galt1 | |
NM_022305 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (B4galt1), mRNA [NM_022305] |
KLA | .58 |
.56 |
.55 |
.59 |
.75 |
1.18 |
1.17 |
| ATP | 1.10 |
1.15 |
1.07 |
1.14 |
1.05 |
.71 |
1.11 |
| KLA/ATP | .60 |
.62 |
.62 |
.66 |
.74 |
.71 |
1.10 |
|
B4galt2 | |
NM_017377 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 (B4galt2), mRNA [NM_017377] |
KLA | 1.02 |
.98 |
.98 |
1.02 |
1.04 |
1.04 |
1.00 |
| ATP | .98 |
1.01 |
1.09 |
1.64 |
1.22 |
.96 |
.94 |
| KLA/ATP | .98 |
1.03 |
1.04 |
1.25 |
1.10 |
1.00 |
1.01 |
|
G6pc | |
NM_008061 |
glucose-6-phosphatase, catalytic (G6pc), mRNA [NM_008061] |
KLA | .96 |
.94 |
1.04 |
1.07 |
1.09 |
1.06 |
1.02 |
| ATP | .98 |
1.05 |
1.09 |
1.04 |
1.05 |
1.00 |
1.01 |
| KLA/ATP | 1.03 |
1.05 |
1.06 |
.96 |
1.02 |
1.00 |
.99 |
|
G6pc2 | |
NM_021331 |
glucose-6-phosphatase, catalytic, 2 (G6pc2), mRNA [NM_021331] |
KLA | .99 |
1.03 |
1.00 |
.98 |
.95 |
1.02 |
.98 |
| ATP | .95 |
1.06 |
.97 |
1.08 |
1.16 |
1.26 |
1.04 |
| KLA/ATP | .94 |
.99 |
1.05 |
6.99 |
3.55 |
1.48 |
1.11 |
|
G6pc3 | |
NM_175935 |
glucose 6 phosphatase, catalytic, 3 (G6pc3), mRNA [NM_175935] |
KLA | .88 |
.89 |
.89 |
.80 |
.75 |
.68 |
.88 |
| ATP | .99 |
1.05 |
.95 |
1.14 |
.92 |
.64 |
.81 |
| KLA/ATP | .92 |
.90 |
.79 |
.94 |
.70 |
.62 |
.58 |
|
Gaa | |
NM_008064 |
glucosidase, alpha, acid (Gaa), mRNA [NM_008064] |
KLA | .85 |
.84 |
.84 |
.78 |
.83 |
.87 |
1.18 |
| ATP | .97 |
.96 |
.75 |
.78 |
.74 |
.72 |
1.01 |
| KLA/ATP | .88 |
.91 |
.78 |
.78 |
.71 |
.71 |
.86 |
|
Gale | |
NM_178389 |
galactose-4-epimerase, UDP (Gale), mRNA [NM_178389] |
KLA | .74 |
.68 |
.72 |
.72 |
.67 |
.68 |
.54 |
| ATP | 1.13 |
.96 |
1.10 |
.91 |
.82 |
1.20 |
1.42 |
| KLA/ATP | .74 |
.69 |
.84 |
.71 |
.93 |
1.03 |
1.13 |
|
Galk1 | |
NM_016905 |
galactokinase 1 (Galk1), mRNA [NM_016905] |
KLA | .85 |
.85 |
.76 |
.72 |
.63 |
.46 |
.50 |
| ATP | 1.02 |
1.07 |
1.02 |
1.33 |
1.01 |
.53 |
.62 |
| KLA/ATP | .90 |
.94 |
.87 |
1.00 |
.79 |
.50 |
.35 |
|
Galk2 | |
NM_175154 |
galactokinase 2 (Galk2), mRNA [NM_175154] |
KLA | .86 |
.78 |
.66 |
.78 |
.65 |
.65 |
.67 |
| ATP | .96 |
.83 |
.79 |
.61 |
.54 |
.66 |
.95 |
| KLA/ATP | .62 |
.68 |
.67 |
.50 |
.42 |
.70 |
.94 |
|
Galt | |
NM_016658 |
galactose-1-phosphate uridyl transferase (Galt), mRNA [NM_016658] |
KLA | .63 |
.59 |
.54 |
.59 |
.57 |
.79 |
1.08 |
| ATP | .88 |
.77 |
.92 |
.79 |
.74 |
.88 |
.95 |
| KLA/ATP | .53 |
.53 |
.60 |
.49 |
.59 |
.80 |
1.10 |
|
Ganc | |
NM_172672 |
glucosidase, alpha; neutral C (Ganc), mRNA [NM_172672] |
KLA | 1.02 |
.97 |
1.02 |
1.00 |
1.00 |
.98 |
.98 |
| ATP | 1.06 |
1.04 |
1.03 |
1.00 |
.71 |
.71 |
1.05 |
| KLA/ATP | 1.02 |
1.09 |
1.18 |
.97 |
.83 |
.79 |
1.07 |
|
Gck | |
NM_010292 |
glucokinase (Gck), mRNA [NM_010292] |
KLA | 1.03 |
.99 |
1.04 |
1.02 |
.97 |
.98 |
1.00 |
| ATP | 1.01 |
.97 |
1.08 |
.99 |
1.06 |
.98 |
.96 |
| KLA/ATP | 1.06 |
1.01 |
.96 |
.98 |
.98 |
1.01 |
1.01 |
|
Gla | |
NM_013463 |
galactosidase, alpha (Gla), mRNA [NM_013463] |
KLA | .91 |
.95 |
1.02 |
.93 |
1.02 |
1.35 |
1.99 |
| ATP | 1.06 |
1.22 |
1.08 |
1.49 |
1.31 |
1.44 |
3.32 |
| KLA/ATP | 1.01 |
1.05 |
.89 |
1.54 |
1.26 |
1.98 |
5.13 |
|
Gla | |
U34071 |
alpha-galactosidase A mRNA, complete cds. [U34071] |
KLA | .99 |
.99 |
1.18 |
1.28 |
1.30 |
1.59 |
1.66 |
| ATP | 1.12 |
1.20 |
1.32 |
1.74 |
1.93 |
1.44 |
1.50 |
| KLA/ATP | 1.12 |
1.24 |
1.28 |
1.98 |
2.55 |
2.85 |
2.82 |
|
Glb1 | |
NM_009752 |
galactosidase, beta 1 (Glb1), mRNA [NM_009752] |
KLA | .93 |
.96 |
1.02 |
.85 |
.86 |
.81 |
.80 |
| ATP | 1.03 |
1.10 |
1.01 |
1.13 |
.97 |
.82 |
.75 |
| KLA/ATP | 1.08 |
1.04 |
.86 |
1.06 |
.81 |
.81 |
.66 |
|
Hk1 | |
J05277 |
gb|Mouse hexokinase mRNA, complete cds [J05277] |
KLA | 1.49 |
1.45 |
1.66 |
1.78 |
1.51 |
1.29 |
.99 |
| ATP | 1.11 |
1.05 |
1.15 |
1.20 |
2.31 |
2.17 |
1.09 |
| KLA/ATP | 1.63 |
1.51 |
1.70 |
1.47 |
1.94 |
1.92 |
1.40 |
|
Hk1 | |
NM_010438 |
hexokinase 1 (Hk1), nuclear gene encoding mitochondrial protein, mRNA [NM_010438] |
KLA | 1.58 |
1.75 |
2.05 |
1.84 |
1.96 |
1.67 |
1.31 |
| ATP | 1.06 |
1.25 |
1.01 |
1.49 |
2.23 |
1.79 |
1.20 |
| KLA/ATP | 1.87 |
1.96 |
1.51 |
1.93 |
1.71 |
1.94 |
1.72 |
|
Hk2 | |
NM_013820 |
hexokinase 2 (Hk2), mRNA [NM_013820] |
KLA | 4.09 |
4.09 |
3.17 |
2.37 |
1.53 |
1.62 |
2.02 |
| ATP | .98 |
.92 |
1.08 |
2.24 |
3.82 |
3.86 |
.97 |
| KLA/ATP | 4.07 |
3.94 |
4.17 |
3.53 |
5.42 |
4.65 |
1.54 |
|
Hk3 | |
NM_001033245 |
hexokinase 3 (Hk3), nuclear gene encoding mitochondrial protein, mRNA [NM_001033245] |
KLA | 1.52 |
1.68 |
1.94 |
1.85 |
2.21 |
2.89 |
1.98 |
| ATP | 1.01 |
1.07 |
.87 |
.99 |
1.01 |
1.26 |
2.62 |
| KLA/ATP | 1.63 |
1.74 |
1.67 |
1.69 |
1.44 |
2.01 |
3.53 |
|
Hkdc1 | |
NM_145419 |
hexokinase domain containing 1 (Hkdc1), mRNA [NM_145419] |
KLA | 1.10 |
1.08 |
1.12 |
1.12 |
1.02 |
1.07 |
1.04 |
| ATP | .96 |
1.04 |
1.06 |
4.28 |
10.50 |
3.91 |
1.34 |
| KLA/ATP | .98 |
1.04 |
1.14 |
5.33 |
12.44 |
8.68 |
1.77 |
|
Lalba | |
NM_010679 |
lactalbumin, alpha (Lalba), mRNA [NM_010679] |
KLA | 1.22 |
1.08 |
1.11 |
1.30 |
1.21 |
1.45 |
1.04 |
| ATP | .90 |
.93 |
1.44 |
1.16 |
1.30 |
1.43 |
1.24 |
| KLA/ATP | 1.10 |
1.20 |
1.71 |
1.50 |
1.52 |
1.69 |
1.47 |
|
Lct | |
NM_001081078 |
lactase (Lct), mRNA [NM_001081078] |
KLA | .93 |
.83 |
.71 |
.83 |
.89 |
.99 |
.84 |
| ATP | 1.03 |
.98 |
.86 |
.92 |
.82 |
.85 |
.85 |
| KLA/ATP | .80 |
.88 |
.75 |
.78 |
.89 |
.87 |
.86 |
|
Mgam | |
AK033548 |
adult male colon cDNA, RIKEN full-length enriched library, clone:9030616M21 product:hypothetical protein, full insert sequence. [AK033548] |
KLA | 1.16 |
1.20 |
1.22 |
1.21 |
1.01 |
1.02 |
1.07 |
| ATP | 1.01 |
1.01 |
1.11 |
2.86 |
5.71 |
5.58 |
1.53 |
| KLA/ATP | 1.24 |
1.24 |
1.29 |
1.64 |
3.84 |
3.69 |
1.98 |
|
Mgam | |
XM_001481277 |
gb|PREDICTED: Mus musculus maltase-glucoamylase (Mgam), mRNA [XM_001481277] |
KLA | 1.03 |
1.04 |
1.03 |
1.04 |
.95 |
.98 |
1.06 |
| ATP | 1.06 |
.94 |
1.05 |
1.42 |
2.38 |
2.12 |
1.16 |
| KLA/ATP | 1.10 |
1.06 |
1.06 |
1.15 |
1.52 |
1.64 |
1.20 |
|
Mm.26105 4 | |
124487274 |
Unknown |
KLA | .95 |
1.04 |
.97 |
.98 |
1.01 |
.94 |
1.10 |
| ATP | 1.00 |
1.06 |
.94 |
1.07 |
1.01 |
1.00 |
.98 |
| KLA/ATP | 1.04 |
.99 |
.93 |
1.01 |
1.11 |
1.07 |
1.04 |
|
Mm.26930
| |
124487296 |
Unknown |
KLA | 1.16 |
1.07 |
1.03 |
1.13 |
1.13 |
1.32 |
1.25 |
| ATP | .99 |
1.00 |
1.05 |
1.24 |
1.38 |
1.37 |
1.06 |
| KLA/ATP | 1.03 |
1.16 |
1.14 |
1.22 |
1.32 |
1.29 |
1.32 |
|
Mm.33401
| |
149255058 |
Unknown |
KLA | 1.03 |
1.07 |
1.00 |
1.03 |
1.01 |
1.03 |
1.06 |
| ATP | 1.12 |
.98 |
1.12 |
1.36 |
2.32 |
2.03 |
1.10 |
| KLA/ATP | 1.03 |
1.00 |
.99 |
1.21 |
1.39 |
1.58 |
1.20 |
|
Pfkl | |
NM_008826 |
phosphofructokinase, liver, B-type (Pfkl), mRNA [NM_008826] |
KLA | 1.19 |
1.33 |
1.34 |
1.23 |
1.57 |
1.49 |
2.02 |
| ATP | 1.17 |
1.34 |
1.04 |
1.45 |
.92 |
1.53 |
.97 |
| KLA/ATP | 1.54 |
1.64 |
1.36 |
1.91 |
1.17 |
.89 |
1.61 |
|
Pfkm | |
NM_021514 |
phosphofructokinase, muscle (Pfkm), mRNA [NM_021514] |
KLA | .73 |
.74 |
.70 |
.88 |
.80 |
.61 |
.55 |
| ATP | 1.09 |
1.05 |
1.01 |
1.06 |
.80 |
.50 |
.52 |
| KLA/ATP | .76 |
.83 |
.86 |
.75 |
.57 |
.57 |
.46 |
|
Pfkp | |
BC050264 |
gb|Mus musculus, clone IMAGE:4503748, mRNA [BC050264] |
KLA | 4.07 |
3.58 |
3.25 |
2.41 |
1.31 |
.76 |
.81 |
| ATP | 1.26 |
1.26 |
2.77 |
2.20 |
4.63 |
2.57 |
4.92 |
| KLA/ATP | 4.81 |
4.66 |
8.95 |
3.50 |
3.96 |
1.60 |
.91 |
|
Pfkp | |
NM_019703 |
phosphofructokinase, platelet (Pfkp), mRNA [NM_019703] |
KLA | 1.94 |
1.99 |
2.15 |
2.05 |
1.90 |
1.20 |
.85 |
| ATP | 1.08 |
1.05 |
1.18 |
1.20 |
1.40 |
1.38 |
.93 |
| KLA/ATP | 1.94 |
2.12 |
2.35 |
2.26 |
1.91 |
1.36 |
.88 |
|
Pgm1 | |
NM_025700 |
phosphoglucomutase 1 (Pgm1), mRNA [NM_025700] |
KLA | 1.08 |
1.03 |
.95 |
.75 |
.59 |
.55 |
.73 |
| ATP | 1.02 |
1.23 |
1.22 |
1.42 |
1.07 |
.75 |
1.01 |
| KLA/ATP | 1.01 |
1.10 |
.84 |
1.12 |
.69 |
.61 |
.51 |
|
Pgm2 | |
NM_028132 |
phosphoglucomutase 2 (Pgm2), mRNA [NM_028132] |
KLA | 1.13 |
1.21 |
1.26 |
1.48 |
1.52 |
1.81 |
1.81 |
| ATP | .90 |
.92 |
1.07 |
.99 |
.80 |
1.60 |
1.17 |
| KLA/ATP | 1.01 |
1.16 |
1.40 |
1.25 |
1.48 |
1.99 |
1.94 |
|
Ugp2 | |
NM_139297 |
UDP-glucose pyrophosphorylase 2 (Ugp2), mRNA [NM_139297] |
KLA | .94 |
1.01 |
.95 |
.96 |
.88 |
1.01 |
1.02 |
| ATP | .97 |
.98 |
1.03 |
.92 |
.94 |
1.19 |
.82 |
| KLA/ATP | .93 |
.94 |
.85 |
.78 |
.82 |
1.20 |
.96 |
|